TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Turn Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$10.74+0.17 (+1.61%)
Close on Oct 19, 2026
- Market cap
- $319.92M
- P/E (TTM)
- –
- Dividend yield
- –
Turn Therapeutics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Turn Therapeutics | Industry median |
|---|---|---|
| Market Cap | $319.92M | $166.30M |
| Enterprise Value | $316.04M | $88.19M |
| PB Ratio | 465.76 | 2.03 |
Income (trailing twelve months)
| Measure | Turn Therapeutics | Industry median |
|---|---|---|
| Operating Income | -$6.98M | -$21.40M |
| Net Income | -$8.45M | -$22.46M |
| EBITDA | -$6.98M | -$16.91M |
| EPS (Diluted) | -$0.29 | -$0.83 |
Returns
| Measure | Turn Therapeutics | Industry median |
|---|---|---|
| Return on Equity (ROE) | -686.3% | -53.2% |
| Return on Assets (ROA) | -49.8% | -40.9% |
| Return on Capital Employed (ROCE) | -85.2% | -38.1% |
Balance sheet
| Measure | Turn Therapeutics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $9.95M | $61.43M |
| Total Debt | $6.06M | $118.52M |
| Net Cash (Debt) | $3.89M | $15.35M |
| Net Cash Per Share | $0.13 | $0.66 |
| Equity (Book Value) | $686.89K | $49.09M |
| Book Value Per Share | $0.02 | $1.37 |
| Tangible Book Value | -$224.33K | $23.52M |
| Working Capital | $1.66M | $76.81M |
Financial position
| Measure | Turn Therapeutics | Industry median |
|---|---|---|
| Current Ratio | 1.19 | 3.34 |
| Quick Ratio | 1.14 | 2.44 |
| Debt / Equity | 8.83 | 0.52 |
Cash flow (trailing twelve months)
| Measure | Turn Therapeutics | Industry median |
|---|---|---|
| Operating Cash Flow | -$4.32M | -$12.35M |
Efficiency
| Measure | Turn Therapeutics | Industry median |
|---|---|---|
| Profits Per Employee | -$4.22M | -$703.34K |
| Employee Count | 2 | 74 |
Dividends and yields
| Measure | Turn Therapeutics | Industry median |
|---|---|---|
| Earnings Yield | -2.64% | -23.3% |
Shares
| Measure | Turn Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 29,788,000 | 58,127,000 |
| Shares Change (YoY) | 7.07% | 10.9% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 13,646,800 | 49,136,700 |
| Shares Held by Insiders | 54.2% | 11.6% |
| Shares Held by Institutions | 3.88% | 59.4% |
Scores
| Measure | Turn Therapeutics | Industry median |
|---|---|---|
| Altman Z-Score | 8.14 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Turn Therapeutics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.